Altered expression levels of TAS1R2 and TAS1R3 genes among SARS-CoV-2 variants of concerns

Qendresa Hoti1, Gokce Akan2, Gulten Tuncel2

  • 1Faculty of Medicine, Department of Medical Biochemistry, Near East University, 99138, Nicosia, Cyprus.

Molecular Biology Reports
|October 10, 2023
PubMed
Abstract

Insights

COVID-19 infection, particularly with the Delta variant, significantly reduces the expression of taste and smell genes (TAS1R2, TAS1R3, TAS2R38). This may explain the temporary taste loss experienced by patients, potentially due to gustatory cell damage.

Area of Science:

  • Genomics
  • Virology
  • Immunology

Background:

  • Common COVID-19 symptoms include fever, cough, shortness of breath, headache, joint pain, and loss of smell and taste.
  • Early research suggests a link between smell/taste receptors, pathogen detection, and immunity.
  • Understanding these receptor gene expressions in COVID-19 patients is crucial for correlating symptoms with viral variants.

Purpose of the Study:

  • To evaluate the gene expression profiles of taste, smell, and appetite-related receptors in COVID-19 patients.
  • To investigate the correlation between these gene expressions and specific SARS-CoV-2 variants.
  • To elucidate the mechanisms behind taste dysfunction in COVID-19.

Main Methods:

  • Gene expression levels of TAS1R2, TAS1R3, TAS2R38, OR51E1, LEPR, and GHRL were analyzed.
  • Analysis was performed on 100 COVID-19 patients and 100 individuals negative for SARS-CoV-2 via RT-qPCR.
  • Statistical correlations between gene expression and viral variants were assessed.

Main Results:

  • Significantly decreased expression of TAS1R2 and TAS1R3 genes was observed in COVID-19 patients infected with the Delta variant.
  • TAS2R38 gene expression was significantly lower in COVID-19 patients compared to the control group.
  • Positive correlations were found between TAS1R2 expression and TAS1R3 (p=0.001), and TAS2R38 (p=0.025) genes.

Conclusions:

  • TAS1R2, TAS1R3, and TAS2R38 gene expression levels were lower in the Delta variant compared to the Omicron BA.1 variant.
  • Reduced gene expression provides a significant clue for temporary taste loss, especially in Delta variant infections.
  • Potential mechanism involves ACE2 expression in taste buds, SARS-CoV-2 replication, inflammation, and gustatory cell damage leading to taste malfunction.